Does peptide therapy work?

Peptides are not magic bullets. They are targeted signalling molecules that support specific biological processes. 'Working' means a measurable change in a specific outcome — better sleep scores, reduced visceral fat on a scan, faster return-to-play from an injury, or improved energy.

The realistic expectation is support, not transformation. A peptide that improves recovery might shave weeks off a nagging injury; it will not make a 50-year-old recover like a 20-year-old. Setting the right expectation before starting is the difference between a protocol that 'worked' and one that 'didn't.'

Sermorelin, CJC-1295 + ipamorelin, and tesamorelin all work by stimulating your pituitary to release growth hormone in natural pulses. The evidence for this category is the strongest in peptide therapy, because growth hormone physiology is well-studied.

Tesamorelin is FDA-approved for reducing excess visceral abdominal fat in HIV-associated lipodystrophy, with human trial data demonstrating measurable body composition changes. Sermorelin has decades of clinical use for growth hormone deficiency. Patients commonly report improved sleep quality, better recovery, and gradual body composition changes over 8 to 16 weeks.

BPC-157 is one of the most requested recovery peptides, and the preclinical evidence is compelling: animal studies show accelerated healing of tendons, ligaments, and muscle tissue, with improved angiogenesis at injury sites. However, human clinical trials are limited — most of the evidence comes from preclinical models plus years of clinical anecdote.

TB-500 (thymosin beta-4) works on a different part of the repair process — cell migration and tissue remodeling. It is often combined with BPC-157 because the two address different phases of healing. Patients managing chronic tendon or ligament issues commonly report shorter recovery timelines, though the evidence base is not as robust as for GH secretagogues.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in cellular energy production, not technically a peptide, but commonly included in peptide protocols because it is administered by injection. NAD+ levels decline with age, and supplementation aims to restore mitochondrial function.

Reports vary widely between individuals. Some patients report a noticeable energy and mental-clarity boost within hours of injection; others notice gradual changes over weeks. The evidence is promising but not conclusive — NAD+ research is active and evolving.

Glutathione is the body's master antioxidant, and injectable glutathione bypasses the gut breakdown that limits oral supplements. The evidence for raising blood glutathione levels via injection is solid; the downstream health benefits are more nuanced.

Patients commonly report improved skin clarity, reduced oxidative stress markers, and support during high-stress or high-training periods. It is supportive care, not a treatment for any specific disease — and claims that go further should be treated with skepticism.

The way to know if peptide therapy works for you is to measure something objective before and after. Without baseline data, any improvement (or lack thereof) is anecdotal.